Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 September 2023 | Story Valentino Ndaba | Photo Unsplash
“Shattering Academic Barriers for Gender Equality"

As we reflect on the significance of Women's Month, which occurred last month, it is worth noting that the Gender Equality and Anti-Discrimination Office (GEADO) at the University of the Free State (UFS) organised a thought-provoking seminar titled, "Bridging the gap: Exploring the Intersection of Traditional African values and Modern Perspectives in Achieving Gender Equality." This event, featuring distinguished guest speakers Prof Nokuzola Mndende and Dr Munyaradzi Mushonga, delved into the historical context of traditional African values and their impact on gender roles and norms. Their primary objective was to discern strategies for fostering dialogue, understanding, and collaboration between traditional and modern stakeholders, all in the noble pursuit of advancing gender equality in Africa.

Tradition versus Modernity

Prof Nokuzola Mndende, an adjunct professor in the Department of Sociology and Anthropology at Nelson Mandela University, as well as the President of We Come Back Spirituality and Founder of Icamagu Heritage Institute, emphasised the importance of African scholars embracing their roots. She stated, "It is important that young African scholars must be bold and change direction and start from home using African tools. In their endeavour to decoloniality, they must not forget their past." She also stressed the need to discard Western theories and spectacles that have been imposed, highlighting the scarcity of literature that portrays the positive aspects of African customs.

Dr Mushonga, the Programme Director for Africa Studies at the UFS Centre for Gender and Africa Studies, drew attention to the impact of modernity on a global scale. He referred to the 1500s when the world was pluricentric, as opposed to the current Eurocentric world order. Dr Mushonga cautioned against the seductive allure of modernity, which tends to cast African traditional perspectives as regressive while promoting Eurocentric ones as progressive.

Fostering equality in Africa

Siyanda Magayana, Senior Officer at the Gender Equality and Anti-Discrimination Office, shed light on the webinar's purpose. She explained, "the webinar intended to critically engage whether there is a gap between African traditional perspectives and values of gender equality against modern perspectives. In addition, we wanted to examine the emergence of modern perspectives and their influence in challenging gender inequality in an African context." She further highlighted the need for African institutions to adopt context-specific approaches to gender equality, rather than relying on Eurocentric models.

Magayana also echoed Prof Mndende's preference for the term "gender equity" over "gender equality," as the latter can inadvertently reinforce a perception of male superiority. Magayana emphasised that achieving gender equity in African contexts should deviate from Eurocentric perspectives, considering the unique histories, understandings, and people in the Global South.

Breaking the glass ceiling

As a prelude to the seminar, GEADO also hosted a webinar in honour of Women’s Month titled "Breaking the Glass Ceiling in Higher Education.” This webinar shed light on the unique challenges women face in academia, addressing implicit biases, stereotypes, and gender-based discrimination. It provided a platform for women to share their triumphs and experiences. Together, these initiatives propel us towards a future marked by diverse leadership and empowered strategies, ultimately promoting gender equality on the continent. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept